Serge Moudio

Centre Hospitalier de Luxembourg — LU

Medicine · Health Sciences

6h-index129citations10works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(3), Renal Transplantation Outcomes and Treatments(3), Pharmacological Effects and Toxicity Studies(3), Gut microbiota and health(1), Nerve injury and regeneration(1)

Publications10 total

A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients
Clinical Pharmacokinetics·2025· 2 citedOpen Access
Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling
Brain and Neuroscience Advances·2025Open Access
Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross‐Sectional Study
Clinical Pharmacology & Therapeutics·2023· 21 citedOpen Access
Publisher Correction: Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
npj Parkinson s Disease·2022· 1 citedOpen Access
Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
npj Parkinson s Disease·2022· 25 citedOpen Access
Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
Frontiers in Neurology·2022· 8 citedOpen Access
Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines
Psychopharmacology·2021· 6 citedOpen Access
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Expert Opinion on Drug Metabolism & Toxicology·2020· 45 citedOpen Access
Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?
Current Drug Targets·2016· 21 cited
Investigating the neuroprotective properties of PAR2
STAX·2016Open Access

Frequent Co-authors

Lukas Pavelka(4), Armin Rauschenberger(4), Sinthuja Pachchek(4), Patrick May(4), Enrico Glaab(4), Rejko Krüger(4), Laure Elens(3), Zied Landoulsi(3), Trevor J. Bushell(3), Alexandra L. Degraeve(2), Vincent Haufroid(2), Djamila Chaïb Eddour(2), Michel Mourad(2), Laure B. Bindels(2), Geeta Acharya(2), Gloria Aguayo(2), Myriam Alexandre(2), Dominic Allen(2), Wim Ammerlann(2), Rudi Balling(2)